These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Role and significance of plasma citrulline in the early phase after small bowel transplantation in pigs. Nadalin S; Biglarnia AR; Testa G; Koppara TR; Schaffer R; Johnson C; Toetsch M; Broelsch CE; Malagó M Transpl Int; 2007 May; 20(5):425-31. PubMed ID: 17313447 [TBL] [Abstract][Full Text] [Related]
10. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study. Kallel L; Ayadi I; Matri S; Fekih M; Mahmoud NB; Feki M; Karoui S; Zouari B; Boubaker J; Kaabachi N; Filali A Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):340-5. PubMed ID: 19581809 [TBL] [Abstract][Full Text] [Related]
11. An association of lower serum citrulline levels within 30 days of acute rejection in patients following small intestine transplantation. David AI; Gaynor JJ; Zis PP; Conanan L; Goldsmith L; Esquenazi V; Selvaggi G; Weppler D; Nishida S; Moon J; Madariaga JR; Ruiz P; Kato T; Levi DM; Kleiner G; Tryphonopoulos P; Tzakis AG Transplant Proc; 2006; 38(6):1731-2. PubMed ID: 16908264 [TBL] [Abstract][Full Text] [Related]
12. Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease. Canani RB; Terrin G; Rapacciuolo L; Miele E; Siani MC; Puzone C; Cosenza L; Staiano A; Troncone R Dig Liver Dis; 2008 Jul; 40(7):547-53. PubMed ID: 18358796 [TBL] [Abstract][Full Text] [Related]
13. Trends in serum citrulline and acute rejection among recipients of small bowel transplants. Pappas PA; Tzakis AG; Saudubray JM; Gaynor JJ; Carreno MR; Huijing F; Kleiner G; Rabier D; Kato T; Levi DM; Nishida S; Gelman B; Thompson JF; Mittal N; Ruiz P Transplant Proc; 2004 Mar; 36(2):345-7. PubMed ID: 15050154 [TBL] [Abstract][Full Text] [Related]
14. [Pediatrics. Fecal calprotectin in children: use and interpretation]. Ezri J; Nydegger A Rev Med Suisse; 2011 Jan; 7(277):69-70. PubMed ID: 21309180 [TBL] [Abstract][Full Text] [Related]
15. [Calprotectin: a fecal marker for diagnosis and follow-up in patients with chronic inflammatory bowel disease]. van den Bergh FA; Kolkman JJ; Russel MG; Vlaskamp RT; Vermes I Ned Tijdschr Geneeskd; 2003 Nov; 147(48):2360-5. PubMed ID: 14677476 [TBL] [Abstract][Full Text] [Related]
16. Normalization of faecal calprotectin: a predictor of mucosal healing in patients with inflammatory bowel disease. Røseth AG; Aadland E; Grzyb K Scand J Gastroenterol; 2004 Oct; 39(10):1017-20. PubMed ID: 15513345 [No Abstract] [Full Text] [Related]
17. [Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report]. Krzesiek E; Iwańczak B Pol Merkur Lekarski; 2010 Oct; 29(172):241-6. PubMed ID: 21207640 [TBL] [Abstract][Full Text] [Related]
18. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Crenn P; Messing B; Cynober L Clin Nutr; 2008 Jun; 27(3):328-39. PubMed ID: 18440672 [TBL] [Abstract][Full Text] [Related]
19. Citrulline evaluation in bowel transplantation. Ruiz P; Tryphonopoulos P; Island E; Selvaggi G; Nishida S; Moon J; Berlanga A; Defranc T; Levi D; Tekin A; Tzakis AG Transplant Proc; 2010; 42(1):54-6. PubMed ID: 20172280 [TBL] [Abstract][Full Text] [Related]
20. Monitoring of rejection and perfusion injury in small bowel transplantation: alkaline phosphatase as a serum marker enzyme in the rat model. Schweizer E; Fändrich F; Schröder J; Deltz E; Schroeder P Transplant Proc; 1994 Jun; 26(3):1552. PubMed ID: 8030031 [No Abstract] [Full Text] [Related] [Next] [New Search]